
Give the Gift of Choice!
Too many options? Treat your friends and family to their favourite stores with a Bayshore Shopping Centre gift card, redeemable at participating retailers throughout the centre. Click below to purchase yours today!Purchase HereHome
Artificial Intelligence Radiation Therapy: First International Workshop, AIRT 2019, Held Conjunction with MICCAI Shenzhen, China, October 17, Proceedings
Coles
Loading Inventory...
Artificial Intelligence Radiation Therapy: First International Workshop, AIRT 2019, Held Conjunction with MICCAI Shenzhen, China, October 17, Proceedings in Ottawa, ON
By None
Current price: $64.49
Original price: $80.62


By None
Artificial Intelligence Radiation Therapy: First International Workshop, AIRT 2019, Held Conjunction with MICCAI Shenzhen, China, October 17, Proceedings in Ottawa, ON
Current price: $64.49
Original price: $80.62
Loading Inventory...
Size: Kobo eBook
*Product information may vary - to confirm product availability, pricing, shipping and return information please contact Coles
This book constitutes the refereed proceedings of the First International Workshop on Connectomics in Artificial Intelligence in Radiation Therapy, AIRT 2019, held in conjunction with MICCAI 2019 in Shenzhen, China, in October 2019. The 20 full papers presented were carefully reviewed and selected from 24 submissions. The papers discuss the state of radiation therapy, the state of AI and related technologies, and hope to find a pathway to revolutionizing the field to ultimately improve cancer patient outcome and quality of life.
This book constitutes the refereed proceedings of the First International Workshop on Connectomics in Artificial Intelligence in Radiation Therapy, AIRT 2019, held in conjunction with MICCAI 2019 in Shenzhen, China, in October 2019. The 20 full papers presented were carefully reviewed and selected from 24 submissions. The papers discuss the state of radiation therapy, the state of AI and related technologies, and hope to find a pathway to revolutionizing the field to ultimately improve cancer patient outcome and quality of life.


















